2619 related articles for article (PubMed ID: 17320566)
1. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
[TBL] [Abstract][Full Text] [Related]
2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
3. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
[TBL] [Abstract][Full Text] [Related]
4. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
Martin J; Siegenthaler MP; Friesewinkel O; Fader T; van de Loo A; Trummer G; Berchtold-Herz M; Beyersdorf F
Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
[TBL] [Abstract][Full Text] [Related]
6. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices.
Zimpfer D; Wieselthaler G; Czerny M; Fakin R; Haider D; Zrunek P; Roethy W; Schima H; Wolner E; Grimm M
ASAIO J; 2006; 52(1):24-7. PubMed ID: 16436886
[TBL] [Abstract][Full Text] [Related]
11. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI
Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674
[TBL] [Abstract][Full Text] [Related]
12. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
[TBL] [Abstract][Full Text] [Related]
13. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
14. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
15. Optimal timing of cardiac transplantation after ventricular assist device implantation.
Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
[TBL] [Abstract][Full Text] [Related]
16. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
17. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device.
Travis AR; Giridharan GA; Pantalos GM; Dowling RD; Prabhu SD; Slaughter MS; Sobieski M; Undar A; Farrar DJ; Koenig SC
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):517-24. PubMed ID: 17258591
[TBL] [Abstract][Full Text] [Related]
18. Load-independent analysis of a pulsatile right ventricular assist device.
Meyers CH; Peterseim DS; Uppal R; Jayawant AM; Campbell KA; Sabiston DC; Smith PK; Van Trigt P
J Heart Lung Transplant; 1995; 14(1 Pt 1):177-85. PubMed ID: 7727467
[TBL] [Abstract][Full Text] [Related]
19. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
[TBL] [Abstract][Full Text] [Related]
20. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.
Etz CD; Welp HA; Tjan TD; Hoffmeier A; Weigang E; Scheld HH; Schmid C
Ann Thorac Surg; 2007 May; 83(5):1697-705. PubMed ID: 17462383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
